Rennova Health, Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was USD 1.01 million compared to USD 1.95 million a year ago. Net income was USD 1.33 million compared to net loss of USD 6.19 million a year ago. Basic loss per share from continuing operations was USD 0.59. Basic loss per share was USD 0.59. For the nine months, sales was USD 1.29 million compared to USD 5.86 million a year ago. Net income was USD 6.51 million compared to net loss of USD 9.86 million a year ago. Basic loss per share from continuing operations was USD 2.75. Basic loss per share was USD 2.68.